Neurobiological Technologies Stock Target Price
Neurobiological Technologies fundamentals help investors to digest information that contributes to Neurobiological Technologies' financial success or failures. It also enables traders to predict the movement of Neurobiological Stock. The fundamental analysis module provides a way to measure Neurobiological Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neurobiological Technologies stock.
Neurobiological |
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
All Next | Launch Module |
Neurobiological Fundamentals
Return On Equity | 1.0 | ||||
Profit Margin | 0.74 % | ||||
Operating Margin | 0.77 % | ||||
Current Valuation | (26.24 M) | ||||
Shares Outstanding | 27.02 M | ||||
Shares Owned By Institutions | 9.41 % | ||||
Number Of Shares Shorted | 37.6 K | ||||
Price To Book | 0.07 X | ||||
Price To Sales | 0.0004 X | ||||
Revenue | 6.03 M | ||||
Gross Profit | 26.35 M | ||||
EBITDA | 19.54 M | ||||
Net Income | 4.94 M | ||||
Cash And Equivalents | 26.49 M | ||||
Cash Per Share | 0.98 X | ||||
Book Value Per Share | 1.07 X | ||||
Cash Flow From Operations | 4.78 M | ||||
Short Ratio | 0.09 X | ||||
Target Price | 6.0 | ||||
Beta | -408.27 | ||||
Market Capitalization | 10.86 K | ||||
Total Asset | 2.58 M | ||||
Working Capital | (73 K) | ||||
Current Liabilities | 73 K | ||||
Z Score | 27.29 | ||||
Net Asset | 2.58 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |